Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP
Stephen Marder, MD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP
Hannah Brown, MD
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Nicholas Whipple, MD, MPH
How Daily Light Habits Influence Migraine in Adolescents
Carlyn Patterson Gentile, MD
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Adriana Della Pietra, MD
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Desiree Matthews, PMHNP-BC
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Sharon Sha, MD, MS
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
Hamid Abuwarda, PhD, BS
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Jeffrey A. Lieberman, MD
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Matcheri S. Keshavan, MD
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Angela Waanders, MD, MPH, MS
Ashley S. Margol, MD, MS
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Caterina Garone, MD, PhD
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
Sheetal Shroff, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.